Results 151 to 160 of about 1,448,905 (180)

Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells. [PDF]

open access: yesCancer Immunol Immunother
Bopp AR   +10 more
europepmc   +1 more source

Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib. [PDF]

open access: yesInt J Mol Sci
Zhao Y   +9 more
europepmc   +1 more source

Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. [PDF]

open access: yesMult Scler
Montalban X   +13 more
europepmc   +1 more source

CNS <i>Neoscytalidium dimidiatum</i>: A Rare Cause of Fungal Brain Abscess. [PDF]

open access: yesCase Rep Surg
Khojah AM   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy